# Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

> **NCT00741455** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **PROCEDURE:** Stem Cell Transplant
- **DRUG:** G-CSF
- **DRUG:** Fludarabine
- **DRUG:** cyclophosphamide
- **DRUG:** Cyclosporine
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00741455
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741455, "Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00741455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*